Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

3B Blackbio DX Ltd Performance

Today's Low
701.50
arrowIcon
Today's High
769.95
52 Wk Low
390.00
arrowIcon
52 Wk High
924.00


Open

769.95

Traded Value (Cr)

31.23 L

Prev. Close

709

VWAP

716.66

Volume

4,404

Face Value

10

3B Blackbio DX Ltd Fundamentals

Market Cap
₹ 529 Cr
P/E Ratio (TTM)
18.67
P/B Ratio
2.56
Debt to Equity
0.01
ROE
12.66 %
EPS (TTM)
37.79
Dividend Yield
0.35%
Book Value
276.09

Click here to know more about Fundamentals

3B Blackbio DX Ltd Financials

3B Blackbio DX Ltd Financials

3B Blackbio DX Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Retail 41.94 % 43.01 % 43.38 % 45.34 %
Promoters 41.29 % 38.43 % 38.43 % 38.43 %
Others 13.80 % 15.17 % 15.04 % 13.17 %
FII 2.97 % 3.38 % 3.16 % 3.06 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Retail

41.94%

Promoters

41.29%

Others

13.80%

FII

2.97%

Mutual Funds

0.00%

Retail

43.01%

Promoters

38.43%

Others

15.17%

FII

3.38%

Mutual Funds

0.00%

Retail

43.38%

Promoters

38.43%

Others

15.04%

FII

3.16%

Mutual Funds

0.00%

Retail

45.34%

Promoters

38.43%

Others

13.17%

FII

3.06%

Mutual Funds

0.00%

Resistance and Support

₹707.98

PIVOT

resistance-arrow
Resistance
First Resistance₹720.967
Second Resistance₹732.933
Third Resistance₹745.917
support-arrow
Support
First Resistance₹696.017
Second Resistance₹683.033
Third Resistance₹671.067
RSI35.058
MACD-12.869
ADX13.663
CCI-103.620

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day2,9112,50756.93
Week6,7044,93673.48
1 Month9,6157,06475.94
6 Months000.00

About 3B Blackbio DX Ltd

3D Blackbio DX Ltd (Formerly known Kilpest India Ltd) was incorporated on May 25, 1972, as one of India's leading Agri-based companies. Shri R.K. Dubey is the founder of this Company. It was the only pesticide formulating company in the entire region of Madhya Pradesh in 1970s. The company has now grown over the years and is leading today in Central India and manufactures about 50 pesticide products, microfertilizers, biofertilizers and biopesticides. The Company has representation in India in the field of agriculture business comprising crop protection, public health products and bio-products and is reputed reliable supplier to various Govt. organizations, such as Directorate General of Supplies & Transport, New Delhi, NAVY, Vishakapatnam/Mumbai, Food Corporation of India Raipur/ Bhopal/ Lucknow/ Mumbai/ Jaipur, NTPC, Bilaspur, Directorate of Health Service, M.P/Maharashtra/AP, Directorate of General Of Health Organization, Gujarat/U.P, Directorate General of Health services, MOH&FW (NVBDCP), Govt. of India, M/s Hindustan Latex Ltd, Noida, Director of Agriculture and Horticulture, M.P./Trivandrum, Central/Western Railway, Mumbai, Northern Railway, New Delhi etc. the company has nationwide distribution network of over 2000 dealers. It possess well equipped R&D laboratory duly approved and recognized by DSIR, Ministry of Science and Technology, Government of India. Advanced instrumentation facility supported by equally competent team of scientists and technicians lay down a strong R&D foundation. Clean and hygienic environment ensure the consistency and reliability of results. Laboratory studies are planned, performed, monitored, recorded, applied in small scale field and then tabulated. The products are manufactured to high International specifications with stringent quality control from raw material procurement to finished goods dispatch. The company's manufacturing process is complimented with the technical expertise and it has attained high standard suited to customer needs on 23-7-2002. Kilpest has received accreditation of International standard ISO 9001-2000 certified company. The companyhas diversified manufacturing in the field of micronutrients, bioproducts and plant growth regulators etc. The company is also exporting its products to Bangladesh and Afghanistan. In 2011-12, the Company launched Novel Biotech Indo-Spanish Joint Venture Project in Govindpura, Bhopal, Madhya Pradesh. It ventured into Diagnostic Service. In June, 2020, the Company launched , its single tube multiplex assay for TRUPCR SARS-CoV-2 RTqPCR Kit (Real-Time PCR based detection of SARS-CoV-2 virus) Version 3.2. With this, 3B BlackBio Biotech India Ltd. became first ever Indian molecular diagnostics company to receive US FDA-(EUA). In 2023, through the Scheme of Arrangement, the Holding Company, Kilpest India Ltd was merged with 3B BlackBio Biotech India Ltd and as per the Scheme of Amalgamation, the name of the Company got changed from Kilpest India Ltd to 3B BlackBio DX Ltd.

Managing Director

D K Dubey

Founded

1972

NSE Symbol

3B Blackbio DX Ltd Management

NameDesignation
D K DubeyChairman & Managing Director
N K DubeyWhole-time Director
Shabbar HusainIndependent Director
Mithala DubeyNon Executive Director
Navneet KaurCompany Sec. & Compli. Officer
Abdul Moin KhanIndependent Director
Harihar Prasad ThapakIndependent Director

3B Blackbio DX Ltd News

3D Blackbio DX schedules board meeting
On 29 May 2024
3B Blackbio DX consolidated net profit rises 29.57% in the December 2023 quarter
Sales rise 19.96% to Rs 17.67 crore
3D Blackbio DX to discuss results
On 9 February 2024
Kilpest India consolidated net profit declines 6.66% in the September 2023 quarter
Sales rise 10.80% to Rs 19.18 crore
Kilpest India to table results
On 10 November 2023
Kilpest India schedules board meeting
On 10 October 2023
Kilpest India schedules AGM
On 22 September 2023
Kilpest India to convene board meeting
On 29 August 2023
Kilpest India consolidated net profit rises 55.56% in the June 2023 quarter
Sales rise 22.16% to Rs 14.28 crore
Kilpest India schedules board meeting
On 11 August 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
APOLLOHOSP₹ 83,506 Cr
₹ 5,807.75
(-0.64 %)
83.62
MAXHEALTH₹ 77,286 Cr
₹ 795.20
(-1.04 %)
135.24
MEDANTA₹ 37,490 Cr
₹ 1,396.25
(-1.36 %)
107.24
FORTIS₹ 34,097 Cr
₹ 451.65
(-2.36 %)
447.18
NH₹ 25,403 Cr
₹ 1,243.05
(-2.20 %)
70.87

3B Blackbio DX Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase 3B Blackbio DX Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. 3B Blackbio DX Ltd's share price is ₹709.20 as of May 9, 2024

3B Blackbio DX Ltd's P/E ratio is 18.67 times as of May 9, 2024.

3B Blackbio DX Ltd's most recent financial reports indicate a price-to-book ratio of 2.56, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. 3B Blackbio DX Ltd's market is 530 Cr as on May 9, 2024.

The current financial records of 3B Blackbio DX Ltd show a 12.66% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a 3B Blackbio DX Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. 3B Blackbio DX Ltd's 52-week high and low as of May 9, 2024 are ₹769.95 and ₹701.5 respectively.

As of the Mar 2024 quarter, the promoter shareholding in 3B Blackbio DX Ltd stands at 41.29%. During the same period, Institutional Investors have shown a slight decrease in their holdings, dropping from 3.38% to 2.97%.